Editorial: What worrying asthma figures tell us about us as a society
“Data released last week shows the number of New Zealanders hampered by asthma or serious lung disease has grown by more than 40% in three years.”
Bovhyaluronidase azoximer for long-term pulmonary sequelae of COVID-19: a randomized, double-blind, placebo-controlled trial
bovhyaluronidase azoximer improved exercise tolerance and reduced breathlessness in post-COVID-19 patients.
Faster lung recovery was noted in those with cardiovascular issues after 180 days.
Arthritis medications could reverse COVID lung damage
“Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of Virginia School of Medicine and Cedars-Sinai suggests.
By examining damaged human lungs and developing an innovative new lab model, the scientists identified faulty immune processes responsible for the ongoing lung issues that plague an increasing number of people after they've otherwise recovered from COVID-19. These lasting harms of COVID infection, known as ‘post-infection lung fibrosis,’ have no good treatments. The new research, however, suggests that existing drugs such as baricitinib and anakinra can disrupt the malfunctioning immune response and finally allow damaged lungs to heal.”
Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of Virginia School of Medicine and Cedars-Sinai suggests.
By examining damaged human lungs and developing an innovative new lab model, the scientists identified faulty immune processes responsible for the ongoing lung issues that plague an increasing number of people after they've otherwise recovered from COVID-19. These lasting harms of COVID infection, known as "post-infection lung fibrosis," have no good treatments. The new research, however, suggests that existing drugs such as baricitinib and anakinra can disrupt the malfunctioning immune response and finally allow damaged lungs to heal.
Zero /dd on Twitter / X
“My lungs aged 19 years after having COVID.
After 18 months and numerous interventions, my lungs still have not regained full capacity.
- In 2021, my lung capacity was age 26.
- By Nov 2022, after getting covid, my lung capacity was age 45.
- Now 2024, my lung capacity is age 37.
My covid symptoms were very mild and lasted only 3 days. Lung therapies below.”
Lung perfusion assessment in children with long‐COVID: A pilot study
Lung perfusion assessment in children with long-COVID: A pilot study
Long-Term Effect of COVID-19 on Lung Imaging and Function, Cardiorespiratory Symptoms, Fatigue, Exercise Capacity, and Functional Capacity in Children and Adolescents: A Systematic Review and Meta-Analysis
Long-Term Effect of COVID-19 on Lung Imaging and Function, Cardiorespiratory Symptoms, Fatigue, Exercise Capacity, and Functional Capacity in Children and Adolescents: A Systematic Review and Meta-Analysis
Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection
Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection
COVID-19 symptoms can linger for months in people with PAH, CTEPH...
“Long COVID syndrome can be common among people with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), affecting more than 60% of patients infected with the SARS-CoV-2 virus in a study from Poland.”
Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review
"Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review"
Chris Turnbull on Twitter
Horrific: Covid double lung transplant:
'This is terrible looking lungs my god look it's like a bomb'
Chris Turnbull on Twitter
'Alarming' asymptomatic 'silent' & 'mild' Covid found to cause severe progressive lung scarring (fibrosis:) that unlike other lung fibrosis that 'usually occurs in the elderly, post-COVID fibrosis is seen irrespective of age and other co-morbidities', shows new study.
A silent march-Post covid fibrosis in asymptomatics – A cause for concern?
significant proportion of patients with asymptomatic to mild COVID-19 cases have demonstrated ground-glass opacities and pneumonia on HRCT.7 However, the impact on lung function over medium to long term and silent progression to fibrosis remains unclear"
25% of COVID-19 patients have lasting reduction in lung function
"25% of COVID-19 patients have lasting reduction in lung function"
Long Covid: Hidden lung damage spotted on scans
"Long Covid: Hidden lung damage spotted on scans"
Dr Graham Lloyd-Jones on Twitter
Not new but this study neatly illustrates the vascular nature of acute #COVID lung disease.
The image shows small blood vessels (red) at the edges of the lungs are shut down & bigger vessels (blue) in the central lungs are enlarged.
#COVIDISNOTPNEUMONIA
Assessment of Small Pulmonary Blood Vessels in COVID-19 Patients Using HRCT
Assessment of Small Pulmonary Blood Vessels in COVID-19 Patients Using HRCT
A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
Lasting Lung Damage Seen in Children and Teens after COVID
"Children and adolescents who have either recovered from COVID-19 or have long COVID show persistent lung damage on MRI, according to a study published in Radiology"
Altered lung physiology in two cohorts after COVID-19 infection as assessed by computed cardiopulmonography - PubMed
Altered lung physiology in two cohorts after COVID-19 infection as assessed by computed cardiopulmonography
Farid Jalali, MD on Twitter
“Irrespective of COVID severity … ⬆️ ventilation homogeneity 𝗲𝗾𝘂𝗶𝘃𝗮𝗹𝗲𝗻𝘁 𝘁𝗼 𝘁𝗵𝗮𝘁 𝗮𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝟭𝟱 𝘆𝗲𝗮𝗿𝘀 𝗼𝗳 𝗮𝗴𝗶𝗻𝗴”